Behind the Paper
The real stories behind the latest research papers, from conception to publication, the highs and the lows
Quantifying how Single Dose Ad26.COV2.S Vaccine Efficacy Depends on Spike Sequence Features
The phase 3 ENSEMBLE trial of a single dose of Janssen’s Ad26.COV2.S vaccine showed an overall vaccine efficacy of 56% against symptomatic COVID-19. Looking at the Spike sequences of infecting viruses reveals a more complex picture.
PIEZO1 mechanically regulates the antitumour cytotoxicity of T lymphocytes
We identified PIEZO1 as a mechanical sensor to regulate the mechanical signaling that is critical for the cytotoxic T cells (CTLs) against tumor cells, creating potential venues to enhance the efficacy of targeted T cell immune therapies.
Behind the Paper: A Deep Dive into the European Green Deal and its Connection with the SDGs
Our paper, "Assessing the Sustainability of the European Green Deal (EGD) and its Interlinkages with the SDGs," evaluates the alignment of EGD with the Sustainable Development Goals, the core of Agenda 2030 and the most common and widely accepted framework of sustainable development.
